MORIN-HEIGHTS, QC, Aug. 22, 2016 /CNW Telbec/ - Capital Pro-Égaux
Inc. (the "Company") (NEX: CPE.H) announces that its wholly owned
subsidiary, Technique d'usinage Sinlab Inc. ("Sinlab"), has entered
into a Patent License Agreement with James R. Glidewell Dental
Ceramics, Inc. ("Glidewell"). As part of the agreement, Sinlab
granted Glidewell and its affiliates a non-exclusive worldwide
license to make, use, sell, offer to sell and import in
the United States inventions
covered by its patents, including patents relating to its Technobar
and Technoguide technologies, under terms undisclosed for
confidentiality reasons.
Unlicensed entities should obtain an appropriate license from
Sinlab by contacting M. Jean Kingsley at
jeanjkingsley@outlook.com.
The Company previously announced settlement and/or license
agreements that include Biomet 3i, LLC (formerly Implant
Innovations, Inc.); Delcam USA,
Inc. and Delcam Holdings, Inc.; Cagenix, Inc.; Dentsply
International Inc.; Nobel Biocare AB; Nobel Biocare Italiana
S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH;
Nobel Biocare Canada, Inc.; Biocad Médical Inc.; Nobel Biocare
USA, LLC; Nobel Biocare Procera,
LLC; 3Shape A/S, exocad America, Inc., MIS Implants Technologies,
Ltd. and SICAT Gmbh & Co. KG. The Company is currently pursuing
its licensing program with other industry participants. The
Company cannot predict the outcome of its ongoing negotiations or
of any legal proceedings it may decide to institute against those
entities that fail or refuse to contract a license. The decision to
take legal proceedings will be based on available information and
the Company's assessment of all relevant facts and circumstances,
including costs involved with such proceedings. Such costs are
unpredictable and may be substantial.
Caution regarding forward-looking statements
This news release contains certain forward-looking statements
regarding the Company's expectation of future events, including
potential claims and the institution of legal proceedings. Such
expectations are based on certain assumptions based on currently
available information. If these assumptions prove incorrect, actual
results may differ materially from those contemplated by the
forward-looking statements contained in this press release. Factors
that could lead actual results to differ include, amongst others,
factors that may impact claims and legal proceedings, such as
interpretation of factual matters, time and money involved in
undertaking legal proceedings, uncertainty as to the final result
and other risks. The Company disclaims any intention or obligation
to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
other than as required by securities laws.
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique
d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the
conception and design of titanium products to be used in the dental
prosthesis restoration industry.
Neither NEX, the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of NEX
and the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
SOURCE Capital Pro-Egaux Inc.